关注
Mats Karlsson
Mats Karlsson
在 farmaci.uu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models
M Bergstrand, AC Hooker, JE Wallin, MO Karlsson
The AAPS journal 13, 143-151, 2011
13252011
Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM
EN Jonsson, MO Karlsson
Computer methods and programs in biomedicine 58 (1), 51-64, 1998
11491998
The FIELDS instrument suite for Solar Probe Plus: measuring the coronal plasma and magnetic field, plasma waves and turbulence, and radio signatures of solar transients
SD Bale, K Goetz, PR Harvey, P Turin, JW Bonnell, T Dudok de Wit, ...
Space science reviews 204, 49-82, 2016
6832016
Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose
RJ Keizer, MO Karlsson, A Hooker
CPT: pharmacometrics & systems pharmacology 2 (6), 1-9, 2013
6632013
Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions
RM Savic, MO Karlsson
The AAPS journal 11, 558-569, 2009
6502009
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs
LE Friberg, A Henningsson, H Maas, L Nguyen, MO Karlsson
Journal of clinical oncology 20 (24), 4713-4721, 2002
6392002
The importance of modeling interoccasion variability in population pharmacokinetic analyses
MO Karlsson, LB Sheiner
Journal of pharmacokinetics and biopharmaceutics 21 (6), 735-750, 1993
6281993
Diagnosing model diagnostics
MO Karlsson, RM Savic
Clinical Pharmacology & Therapeutics 82 (1), 17-20, 2007
6012007
Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies
RM Savic, DM Jonker, T Kerbusch, MO Karlsson
Journal of pharmacokinetics and pharmacodynamics 34, 711-726, 2007
5952007
The axial double probe and fields signal processing for the MMS mission
RE Ergun, S Tucker, J Westfall, KA Goodrich, DM Malaspina, D Summers, ...
Space Science Reviews 199, 167-188, 2016
5872016
Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method
AC Hooker, CE Staatz, MO Karlsson
Pharmaceutical research 24, 2187-2197, 2007
4072007
Pharmacokinetics and safety of intravenous voriconazole in children after single-or multiple-dose administration
TJ Walsh, MO Karlsson, T Driscoll, AG Arguedas, P Adamson, ...
Antimicrobial agents and chemotherapy 48 (6), 2166-2172, 2004
4072004
Handling data below the limit of quantification in mixed effect models
M Bergstrand, MO Karlsson
The AAPS journal 11, 371-380, 2009
3632009
Automated covariate model building within NONMEM
EN Jonsson, MO Karlsson
Pharmaceutical research 15, 1463-1468, 1998
3511998
Assessment of actual significance levels for covariate effects in NONMEM
U Wählby, EN Jonsson, MO Karlsson
Journal of pharmacokinetics and pharmacodynamics 28, 231-252, 2001
3502001
Likelihood based approaches to handling data below the quantification limit using NONMEM VI
JE Ahn, MO Karlsson, A Dunne, TM Ludden
Journal of pharmacokinetics and pharmacodynamics 35, 401-421, 2008
3462008
Irinotecan pathway genotype analysis to predict pharmacokinetics
RHJ Mathijssen, S Marsh, MO Karlsson, R Xie, SD Baker, J Verweij, ...
Clinical cancer research 9 (9), 3246-3253, 2003
3252003
Model evaluation of continuous data pharmacometric models: metrics and graphics
THT Nguyen, MS Mouksassi, N Holford, N Al‐Huniti, I Freedman, ...
CPT: pharmacometrics & systems pharmacology 6 (2), 87-109, 2017
3122017
Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium
CH van der Wouden, A Cambon‐Thomsen, E Cecchin, KC Cheung, ...
Clinical Pharmacology & Therapeutics 101 (3), 341-358, 2017
2942017
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies
MO Karlsson, I Lutsar, PA Milligan
Antimicrobial agents and chemotherapy 53 (3), 935-944, 2009
2532009
系统目前无法执行此操作,请稍后再试。
文章 1–20